Summary
A new analysis of the risks and benefits of offering two doses of COVID-19 vaccination to all 12-17 year olds in England shows that the benefits clearly outweigh the risks, given the current high case rates. In the UK currently a single dose of vaccine is recommended for all 12-17 year olds.
The research, which is in press with the Journal of the Royal Society of Medicine, estimates hospital and ICU admissions, deaths and cases of long COVID averted over a 16-week period by vaccinating all 12-17 year olds in England. The analysis includes high and low case rate scenarios.
New analysis shows benefits of offering two doses of COVID-19 vaccine to children aged 12-17 clearly outweigh risks (30 September 2021)
https://www.rsm.ac.uk/media-releases/2021/new-analysis-shows-benefits-of-offering-two-doses-of-covid-19-vaccine-to-children-aged-12-17-clearly-outweigh-risks/
0
reactions so far
0 Comments
Recommended Comments
There are no comments to display.
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now